Loading viewer...
earnings
Format: PDF earnings
NATCO Pharma Limited presents Q1 FY2024 results as a diversified pharmaceutical enterprise with strong oncology positioning in India and complex generics focus in US markets. The company operates across three regions (India, US, ROW) with 4,900 employees and reported total revenues of ₹28,117 million for FY2023, supported by market capitalization of USD 1.51 billion.
earnings
28 Pages
Constellium
Antero Midstream Partners Q3 2016 Earnings Presentation
earningsearnings
11 Pages
Antero Midstream Partners LP
OMV Q3 2016 Earnings Conference Call Results
earningsearnings
22 Pages
OMV Aktiengesellschaft